In the present paper, we develop a mathematical model that describes the anti-tumor activity of CD8+ T cells in terms of IFN- and IL-10 productions, when these T cells are activated by IL-27 from the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.